Janus Capital Group, Inc. (NYSE:JNS) said its total assets under management were $183.1 billion at Dec. 31, up from $174.4 billion on Sept. 30. Fourth-quarter net income rose to $46.7 million, or 24 cents per share, from $38.3 million, or 21 cents per share, a year earlier. The results beat the analysts’ average estimate by 4 cents a share, according to Thomson Reuters I/B/E/S. On Thursday shares of Janus Capital Group, Inc. (NYSE:JNS) closed at $18.39. Company’s sales growth for last 5 years was -3.40% and EPS growth for next 5 years is recorded as 18.00%.
Goldman Sachs cut shares of Yandex NV (NASDAQ:YNDX) from a neutral rating to a sell rating in a research note issued to investors on Monday, TheFlyOnTheWall.com reports. The firm currently has $14.80 price target on the stock, down from their previous price target of $293.30. Yandex N.V. (NASDAQ:YNDX) in last trading activity moved up 5.75% to close at $17.46. Company weekly performance is -5.11% while its quarterly performance stands at -36.32%. Yandex N.V. (NASDAQ:YNDX) is -60.32% away from its 52 week high.
Cvent, Inc. (NYSE:CVT), a leading cloud-based enterprise event management platform formally announced the date and location of Cvent Connect. The company will be hosting three conferences at the same time during the span of a week. The five day event will take place in Las Vegas from June 14-18 at the MGM Grand Hotel & Casino. On last trading day Cvent, Inc. (NYSE:CVT) moved up 0.15% to close at $27.46. Its volatility for the week is 2.91% while volatility for the month is 2.50%. CVT’s sales growth for past 5 years was 33.60% and its EPS growth for past 5 years was -29.40%. Cvent, Inc. (NYSE:CVT) monthly performance is 0.29%.
Hyperion Therapeutics, Inc. (NASDAQ:HPTX) on 12 January announced the online publication in Genetics in Medicine of analyses from four short-term switchover (SO) studies and three 12-month safety extension studies examining the relationships between fasting ammonia, daily ammonia exposure, and hyperammonemic crises (HAC) in adult and pediatric patients with urea cycle disorders (UCD.) Hyperion Therapeutics, Inc. (NASDAQ:HPTX) has 0.70% insider ownership while its institutional ownership stands at 98.50%. In last trading activity company’s stock closed at $24.94.
ASML Holding NV (NASDAQ:ASML) said first-quarter sales will beat estimates as Europe’s largest chip-equipment maker anticipates rising demand for technology for mobile communication devices. Sales will be about 1.6 billion euros ($1.9 billion) in the first three months of the year, the Veldhoven, Netherlands-based company said in a Wednesday statement. Analysts polled by Bloomberg predicted an average of 1.5 billion euros. On last trading day ASML Holding NV (NASDAQ:ASML) moved up 0.95% to close at $107.60. Its volatility for the week is 1.76% while volatility for the month is 1.62%. ASML’s sales growth for past 5 years was 12.20% and its EPS growth for past 5 years was 19.20%. ASML Holding NV (NASDAQ:ASML) monthly performance is 0.71%.